Balance Sheet Data
AcelRx Pharmaceuticals, Inc. (ACRX)
$0.86
+0.06 (+7.50%)
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
Total Cash | 66.14 | 42.89 | 51.63 | 15.77 | 9.38 | 9.91 | 9.62 | 9.34 | 9.07 | 8.80 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 0.52 | 0.64 | 0.16 | 0.31 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
Account Receivables (%) | ||||||||||
Inventories | 3.30 | 1.63 | 1.11 | 1.18 | 0.46 | 0.44 | 0.43 | 0.42 | 0.40 | 0.39 |
Inventories (%) | ||||||||||
Accounts Payable | 1.72 | 2.74 | 2.12 | 2.04 | 1.34 | 0.66 | 0.64 | 0.62 | 0.60 | 0.58 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -3.47 | -1.85 | -1.83 | -0.36 | -0.10 | -0.36 | -0.35 | -0.34 | -0.33 | -0.32 |
Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.